NURO Stock Summary and Trading Ideas (Neurometrix | NASDAQ:NURO)

NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.

Neurometrix trades on the NASDAQ stock market under the symbol NURO.

As of September 20, 2024, NURO stock price climbed to $3.93 with 16,248 million shares trading.

NURO has a beta of 0.65, meaning it tends to be less sensitive to market movements. NURO has a correlation of 0.03 to the broad based SPY ETF.

NURO has a market cap of $7.96 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, NURO stock traded as high as $123.60 and as low as $2.66.

The top ETF exchange traded funds that NURO belongs to (by Net Assets): VXF.

NURO has underperformed the market in the last year with a price return of -25.1% while the SPY ETF gained +29.5%. However, in the short term, NURO had mixed performance relative to the market. It has outperformed in the last 3 months, returning +5.5% vs +3.9% return in SPY. But in the last 2 weeks, NURO shares have been beat by the market, returning +2.9% compared to an SPY return of +3.4%.

NURO support price is $3.58 and resistance is $4.06 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NURO stock will trade within this expected range on the day.